SCHEMBL23450830

SCHEMBL23450830

Cc1cccc(OCCC2CC2O)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
RAB9A P51151 1/20 0.47
DRD2 P14416 2/20 0.47
DRD4 P21917 2/20 0.47
MEN1 O00255 1/20 0.46
DRD3 P35462 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 1/20 0.45
F2 P00734 1/20 0.43
PPARD Q03181 2/20 0.43
FFAR1 O14842 1/20 0.43
PPARG P37231 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13724658 0.79 L3MBTL1 (0.51) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL29381067 0.77 DRD2 (0.62) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL27465 0.77 DRD2 (0.62) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL14305611 0.77 KMT2A (0.44) L3MBTL1KMT2ATDP1MEN1SMN1; SMN2
SCHEMBL24293939 0.76 PDIA6 (0.40) L3MBTL1KMT2ATDP1RAB9AMEN1
SCHEMBL13645796 0.76 L3MBTL1 (0.49) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL11674802 0.75 DRD2 (0.66) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL30674525 0.75 MEN1 (0.55) L3MBTL1KDM4EKMT2ADRD2DRD4
SCHEMBL516564 0.74 ALDH1A1 (0.57) L3MBTL1KDM4EKMT2ATDP1RAB9A
SCHEMBL30335968 0.74 ALDH1A1 (0.57) L3MBTL1KDM4EKMT2ATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163435-A1 EPOXY REACTIVE DILUENT AND MANUFACTURING METHOD THEREFOR KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2021-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163435-A1 EPOXY REACTIVE DILUENT AND MANUFACTURING METHOD THEREFOR ALOX15B, CYP1B1, ALOX12 L3MBTL1 3376/4885KDM4E 2646/4885KMT2A 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.